Suchergebnisse - "Teixeira, Julio"

PubPharm (10)

1

Determinants of Acquisition and Clearance of Human Papillomavirus Infection in Previously Unexposed Young Women

enthalten in: Sexually transmitted diseases | 2019

von El-Zein, M. | Ramanakumar, A. | Naud, P. | +11

2

Evaluation of Type Replacement Following HPV16/18 Vaccination : Pooled Analysis of Two Randomized Trials

enthalten in: Journal of the National Cancer Institute | 2017

von Tota, J. | Struyf, F. | Merikukka, M. | +22

3

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women : results from the control arm of a phase II HPV-16/18 vaccine trial

enthalten in: BMJ open | 2016

von Ramanakumar, A. | Naud, P. | Roteli-Martins, C. | +13

ErratumIn: BMJ Open. 2016 Sep 02;6(9):e011371corr1. - PMID 27591019

4

Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine : combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials

enthalten in: The Lancet. Oncology | 2015

von Kreimer, A. | Struyf, F. | Del Rosario-Raymundo, M. | +142

CommentIn: BMJ. 2015 Jun 11;350:h3198. - PMID 26067838

5

Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies : analysis of the control arm of PATRICIA

enthalten in: The Journal of infectious diseases | 2014

von Castellsagué, X. | Naud, P. | Chow, S. | +28

CommentIn: J Infect Dis. 2014 Aug 15;210(4):507-9. - PMID 24610878

6

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine : final analysis of a long-term follow-up study up to 9.4 years post-vaccination

enthalten in: Human vaccines & immunotherapeutics | 2014

von Naud, P. | Roteli-Martins, C. | De Carvalho, N. | +7

7

Natural history of progression of HPV infection to cervical lesion or clearance : analysis of the control arm of the large, randomised PATRICIA study

enthalten in: PloS one | 2013

von Jaisamrarn, U. | Castellsagué, X. | Garland, S. | +127

ErratumIn: PLoS One. 2013;8(12). doi:10.1371/annotation/cea59317-929c-464a-b3f7-e095248f229a

8

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

enthalten in: The Lancet. Oncology | 2012

von Wheeler, C. | Castellsagué, X. | Garland, S. | +125

ErratumIn: Lancet Oncol. 2012 Jan;13(1):e1

9

Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia : 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

enthalten in: The Lancet. Oncology | 2012

von Lehtinen, M. | Paavonen, J. | Wheeler, C. | +128

ErratumIn: Lancet Oncol. 2012 Jan;13(1):e1

10

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial

enthalten in: Lancet (London, England) | 2004

von Harper, D. | Franco, E. | Wheeler, C. | +14

CommentIn: Lancet. 2004 Nov 13-19;364(9447):1731-2. - PMID 15541429

1
[1]